Article
Cystic fibrosis transmembrane conductance regulator mutations that disrupt nucleotide binding.
The Journal of clinical investigation - 1 Jul 1994
Logan J, Hiestand D, Daram P, Huang Z, Muccio D D, Hartman J, Haley B, Cook W J, Sorscher E J
Abstract excerpt
Increasing evidence suggests heterogeneity in the molecular pathogenesis of cystic fibrosis (CF). Mutations such as deletion of phenylalanine at position 508 (delta F508) within the cystic fibrosis transmembrane conductance regulator (CFTR), for example, appear to cause disease by abrogating normal biosynthetic processing, a mechanism which results in retention and degradation of the mutant protein within the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
